Cargando…
Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
OBJECTIVE: To evaluate effects of atrial fibrillation (AF) on cardiac biomarkers and outcomes in a trial population of patients with heart failure (HF) with reduced ejection fraction treated with optimal guideline-directed medical therapy. METHODS: We performed a secondary analysis of 894 patients i...
Autores principales: | Chouairi, Fouad, Pacor, Justin, Miller, P. Elliott, Fuery, Michael A., Caraballo, Cesar, Sen, Sounok, Leifer, Eric S., Felker, G. Michael, Fiuzat, Mona, O’Connor, Christopher M., Januzzi, James L., Friedman, Daniel J., Desai, Nihar R., Ahmad, Tariq, Freeman, James V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105522/ https://www.ncbi.nlm.nih.gov/pubmed/33997640 http://dx.doi.org/10.1016/j.mayocpiqo.2021.02.005 |
Ejemplares similares
-
Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction
por: Daubert, Melissa A., et al.
Publicado: (2021) -
Importance of the ‘area under the curve’ from serial NT‐proBNP measurements during treatment with sacubitril/valsartan
por: Mohebi, Reza, et al.
Publicado: (2023) -
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023) -
Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort
por: Welsh, Paul, et al.
Publicado: (2022) -
Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)